These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31435923)

  • 1. Preparation of Cholera Toxin Subunit B Functionalized Nanoparticles for Targeted Therapy of Glioblastoma.
    Guan J; Qian J; Zhan C
    Methods Mol Biol; 2020; 2059():207-212. PubMed ID: 31435923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery.
    Guan J; Zhang Z; Hu X; Yang Y; Chai Z; Liu X; Liu J; Gao B; Lu W; Qian J; Zhan C
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28841776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model.
    Madani F; Morovvati H; Webster TJ; Najaf Asaadi S; Rezayat SM; Hadjighassem M; Khosravani M; Adabi M
    Sci Rep; 2024 Aug; 14(1):19516. PubMed ID: 39174603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles.
    Sousa F; Dhaliwal HK; Gattacceca F; Sarmento B; Amiji MM
    J Control Release; 2019 Sep; 309():37-47. PubMed ID: 31344424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
    Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel Delivery to the Brain for Glioblastoma Treatment.
    AbdEl-Haq M; Kumar A; Ait Mohand FE; Kravchenko-Balasha N; Rottenberg Y; Domb AJ
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
    Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
    Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
    Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
    Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma.
    Ganipineni LP; Ucakar B; Joudiou N; Riva R; Jérôme C; Gallez B; Danhier F; Préat V
    J Drug Target; 2019; 27(5-6):614-623. PubMed ID: 30633585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
    Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
    J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.